W R Fair|M B Garnick - JoVE Visualize

Showing results (191-200 of 309) with videos related to

Pageof 31

Sort By:

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1985

Therapeutic guidelines and results in advanced seminomaE L Friedman, M B Garnick, P C Stomper, et al.

The Journal of Urology|June 1, 1987

Flow cytometric analysis of primary adenocarcinoma of the bladderR A Badalament, E S Cibas, V E Reuter, et al.

The Journal of Urology|December 1, 1988

Flow cytometry and cytology as response indicators to M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin)D K Hermansen, V E Reuter, W F Whitmore, et al.

Clinical Chemistry|October 1, 1992

Abbott IMx evaluated for assay of prostate-specific antigen in serumA M Dnistrian, M K Schwartz, C A Smith, et al.

Cancer Research|December 15, 1990

DNA in situ sensitivity to denaturation in bladder cancer and its correlation with tumor stageP R Bretton, Z Darzynkiewicz, E Henry, et al.

The Journal of Urology|May 1, 1980

Three-day treatment of urinary tract infectionsW R Fair, D B Crane, L J Peterson, et al.

Journal of the National Cancer Institute|January 4, 1995

Reversal by transferrin of growth-inhibitory effect of suramin on hormone-refractory human prostate cancer cellsS M Donat, C T Powell, R S Israeli, et al.

Seminars in Surgical Oncology|September 1, 1992

Cell surface differentiation antigens of normal urothelium and bladder tumorsG Dalbagni, V E Reuter, J Sheinfeld, et al.

The Journal of Urology|February 1, 1988

Detection of carcinoma in the post-cystectomy urethral remnant by flow cytometric analysisD K Hermansen, R A Badalament, W F Whitmore, et al.

Cancer Research|April 1, 1995

Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progressionS L Su, I P Huang, W R Fair, et al.

Pageof 31

Showing results (191-200 of 309) with videos related to

Sort By:

Pageof 31

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1985

Therapeutic guidelines and results in advanced seminomaE L Friedman, M B Garnick, P C Stomper, et al.

The Journal of Urology|June 1, 1987

Flow cytometric analysis of primary adenocarcinoma of the bladderR A Badalament, E S Cibas, V E Reuter, et al.

The Journal of Urology|December 1, 1988

Flow cytometry and cytology as response indicators to M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin)D K Hermansen, V E Reuter, W F Whitmore, et al.

Clinical Chemistry|October 1, 1992

Abbott IMx evaluated for assay of prostate-specific antigen in serumA M Dnistrian, M K Schwartz, C A Smith, et al.

Cancer Research|December 15, 1990

DNA in situ sensitivity to denaturation in bladder cancer and its correlation with tumor stageP R Bretton, Z Darzynkiewicz, E Henry, et al.

The Journal of Urology|May 1, 1980

Three-day treatment of urinary tract infectionsW R Fair, D B Crane, L J Peterson, et al.

Journal of the National Cancer Institute|January 4, 1995

Reversal by transferrin of growth-inhibitory effect of suramin on hormone-refractory human prostate cancer cellsS M Donat, C T Powell, R S Israeli, et al.

Seminars in Surgical Oncology|September 1, 1992

Cell surface differentiation antigens of normal urothelium and bladder tumorsG Dalbagni, V E Reuter, J Sheinfeld, et al.

The Journal of Urology|February 1, 1988

Detection of carcinoma in the post-cystectomy urethral remnant by flow cytometric analysisD K Hermansen, R A Badalament, W F Whitmore, et al.

Cancer Research|April 1, 1995

Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progressionS L Su, I P Huang, W R Fair, et al.

Pageof 31